Assessment of HBV Vaccine Immunity After 18 Years

Immune Response to Hepatitis B Virus Booster Vaccination After 20-23 Years

NCT02166671 ·Status: TERMINATED ·Phase: NA

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

NCT03183492 ·Status: WITHDRAWN ·Phase: PHASE4

Improved Prevention of Perinatal Hepatitis B Transmission

NCT01133184 ·Status: UNKNOWN ·Phase: PHASE4

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00335881 ·Status: COMPLETED ·Phase: PHASE4

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00356564 ·Status: COMPLETED ·Phase: PHASE4

Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-B

NCT02901951 ·Status: COMPLETED ·Phase: PHASE4

Hepatitis B Challenge Dose in Adults (V232-059-10)

NCT01251276 ·Status: COMPLETED ·Phase: PHASE3

New Methods to Measure the Immune Response to Hepatitis B Vaccine

NCT01821547 ·Status: COMPLETED ·Phase: PHASE4

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

NCT05791851 ·Status: COMPLETED

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576 ·Status: COMPLETED ·Phase: PHASE4

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

NCT00984139 ·Status: COMPLETED ·Phase: PHASE4

Understanding Poor Vaccine Responses to Hepatitis B Vaccination

NCT04674462 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Study to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for Chronic Hepatitis B Virus Infection, in Healthy Adults

NCT06989788 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease

NCT01531075 ·Status: COMPLETED ·Phase: NA

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

NCT00697866 ·Status: COMPLETED ·Phase: PHASE3

Study on New Strategies for Hepatitis B Virus Immunization

NCT06515938 ·Status: COMPLETED ·Phase: NA

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

NCT00197158 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients

NCT01933412 ·Status: UNKNOWN ·Phase: PHASE3

Long-term Persistence of Immunity Against Hepatitis B in 7-8 Years Old Children After Hepatitis B Vaccination.

NCT00519649 ·Status: COMPLETED ·Phase: PHASE4

Pilot Study: Gene Expression Profiling of Immune Response to HBV Vaccination in Healthy Volunteers

NCT02055365 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

NCT02153320 ·Status: COMPLETED ·Phase: PHASE1

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

NCT00774995 ·Status: COMPLETED ·Phase: PHASE4

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

NCT01333813 ·Status: COMPLETED ·Phase: PHASE4

Hepatitis B Booster Study in Adolescence

NCT02169674 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

NCT01847430 ·Status: COMPLETED ·Phase: PHASE4